Common Contracts

EX-99.1 5 a18-3548_1ex99d1.htm EX-99.1 Execution Version VOTING AND SUPPORT AGREEMENT

Voting and Support Agreement • May 5th, 2020 • Delaware

• Contract Type
  Voting and Support Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

This VOTING AND SUPPORT AGREEMENT (this “Agreement”) is entered into as of January 21, 2018, by and between Biocryst Pharmaceuticals, Inc., a Delaware corporation (“Boat”), and 667, L.P. and Baker Brothers Life Sciences, L.P. (each, a “Stockholder” and, collectively, the “Stockholders”). Capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among Boat, Idera Pharmaceuticals, Inc., a Delaware corporation (“Island”), Nautilus Holdco, Inc., a Delaware corporation and a wholly owned Subsidiary of Boat (“Holdco”), Island Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Holdco (“Merger Sub A”), and Boat Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Holdco (“Merger Sub B”).

VOTING AND SUPPORT AGREEMENT

Voting and Support Agreement • January 22nd, 2018 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Voting and Support Agreement
• Filed
  January 22nd, 2018
• Company
  Biocryst Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This VOTING AND SUPPORT AGREEMENT (this “Agreement”) is entered into as of January 21, 2018, by and between Biocryst Pharmaceuticals, Inc., a Delaware corporation (“Boat”), and 667, L.P. and Baker Brothers Life Sciences, L.P. (each, a “Stockholder” and, collectively, the “Stockholders”). Capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among Boat, Idera Pharmaceuticals, Inc., a Delaware corporation (“Island”), Nautilus Holdco, Inc., a Delaware corporation and a wholly owned Subsidiary of Boat (“Holdco”), Island Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Holdco (“Merger Sub A”), and Boat Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Holdco (“Merger Sub B”).

VOTING AND SUPPORT AGREEMENT

Voting and Support Agreement • January 22nd, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Voting and Support Agreement
• Filed
  January 22nd, 2018
• Company
  Idera Pharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This VOTING AND SUPPORT AGREEMENT (this “Agreement”) is entered into as of January 21, 2018, by and between Idera Pharmaceuticals, Inc., a Delaware corporation (“Island”), and 667, L.P. and Baker Brothers Life Sciences, L.P. (each, a “Stockholder” and, collectively, the “Stockholders”). Capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among Island, BioCryst Pharmaceuticals, Inc., a Delaware corporation (“Boat”), Nautilus Holdco, Inc., a Delaware corporation and a wholly owned Subsidiary of Boat (“Holdco”), Island Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Holdco (“Merger Sub A”), and Boat Merger Sub, Inc. , a Delaware corporation and a wholly owned Subsidiary of Holdco (“Merger Sub B”).